We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Fair Isaac
FICO
$31B
| $2.9M | 0.01% |
4,838
+3,596
| +290% | +$1.89M |
|
402
Cigna
CI
$79.6B
| $2.88M | 0.01% |
8,682
+6,037
| +228% | +$1.91M |
|
403
United Therapeutics
UTHR
$26.1B
| $2.87M | 0.01% |
10,324
-73,681
| -88% | -$18.6M |
|
404
Liquidity Services
LQDT
$1.23B
| $2.86M | 0.01% |
203,078
+90,302
| +80% | +$1.45M |
|
405
Resources Connection
RGP
$136M
| $2.82M | 0.01% |
153,284
+28,187
| +23% | +$518K |
|
|
406
Booking.com
BKNG
$154B
| $2.79M | 0.01% |
34,550
-2,040,450
| -98% | -$155M |
|
407
AstraZeneca
AZN
$267B
| $2.75M | 0.01% |
20,279
+11,703
| +136% | +$1.47M |
|
408
Ford
F
$59.6B
| $2.64M | 0.01% |
227,394
-459,475
| -67% | -$5.9M |
|
409
RPM International
RPM
$14.3B
| $2.63M | 0.01% |
+26,938
| New | +$2.61M |
|
410
Hubbell
HUBB
$25.6B
| $2.62M | 0.01% |
+11,149
| New | +$2.67M |
|
411
DT Midstream
DTM
$14.1B
| $2.59M | 0.01% |
46,796
+21,861
| +88% | +$1.25M |
|
412
First Horizon
FHN
$12.3B
| $2.52M | 0.01% |
+102,836
| New | +$2.49M |
|
413
Aecom
ACM
$9.57B
| $2.5M | 0.01% |
+29,416
| New | +$2.31M |
|
414
Morgan Stanley
MS
$333B
| $2.47M | 0.01% |
29,092
+3,354
| +13% | +$286K |
|
415
Toro Company
TTC
$9.08B
| $2.47M | 0.01% |
+21,835
| New | +$2.31M |
|
416
Essential Utilities
WTRG
$11.5B
| $2.44M | 0.01% |
+51,066
| New | +$2.31M |
|
417
Graco
GGG
$13.3B
| $2.39M | 0.01% |
35,579
+28,518
| +404% | +$1.9M |
|
418
Fresenius Medical Care
FMS
$13.3B
| $2.38M | 0.01% |
+145,743
| New | +$2.16M |
|
419
Annaly Capital Management
NLY
$17.4B
| $2.34M | 0.01% |
+111,202
| New | +$2.19M |
|
420
Carlisle Companies
CSL
$14.1B
| $2.34M | 0.01% |
+9,914
| New | +$2.55M |
|
421
Vanda Pharmaceuticals
VNDA
$310M
| $2.32M | 0.01% |
313,362
+82,066
| +35% | +$799K |
|
422
CSX Corp
CSX
$94.2B
| $2.29M | 0.01% |
73,880
+2,220
| +3% | +$66.8K |
|
|
WBA
423
DELISTED
Walgreens Boots Alliance
WBA
| $2.26M | 0.01% |
60,526
-175,553
| -74% | -$6.6M |
|
424
Service Corp International
SCI
$11.7B
| $2.24M | 0.01% |
32,364
+29,173
| +914% | +$1.94M |
|
425
Neurocrine Biosciences
NBIX
$18.4B
| $2.2M | 0.01% |
18,422
+14,218
| +338% | +$1.67M |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.